medroxyprogesterone has been researched along with Carcinoma, Intraepithelial in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| CRAIG, JM; KISTNER, RW; STEINER, GJ | 1 |
| Chi, IC; Hatcher, RA; Higgins, JE; Wilkens, LR | 1 |
| Bonhomme, MG; Fortney, JA; Irwin, KL; Lee, NC; Oberle, MW; Rosero-Bixby, L; Whatley, AS | 1 |
| Dabancens, A; Larraguibel, R; Prado, R; Zañartu, J | 1 |
| Stoll, BA | 1 |
| Ferenczy, A; Richart, RM | 1 |
| Starup, J | 1 |
2 review(s) available for medroxyprogesterone and Carcinoma, Intraepithelial
| Article | Year |
|---|---|
Hormonal therapy of gynecologic malignancy.
Topics: Administration, Oral; Adrenal Cortex Hormones; Breast Neoplasms; Carcinoma in Situ; Dimethisterone; Drug Therapy, Combination; Estrogens; Ethynodiol Diacetate; Female; Humans; Hydroxyprogesterones; Injections, Intramuscular; Medroxyprogesterone; Neoplasm Metastasis; Norethindrone; Norpregnanes; Progesterone; Prolactin; Recurrence; Uterine Neoplasms; Uterus | 1973 |
Endometrial morphologic response to hormonal environment.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma in Situ; Cell Transformation, Neoplastic; Endometrium; Epithelium; Estradiol; Estrogens; Female; Humans; Hyperplasia; Male; Medroxyprogesterone; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mucous Membrane; Ovulation; Progesterone Congeners; Ribosomes; Uterine Neoplasms | 1974 |
6 other study(ies) available for medroxyprogesterone and Carcinoma, Intraepithelial
| Article | Year |
|---|---|
HISTOLOGICAL EFFECTS OF PROGESTINS ON HYPERPLASIA AND CARCINOMA IN SITU OF THE ENDOMETRIUM--FURTHER OBSERVATIONS.
Topics: Carcinoma in Situ; Drug Therapy; Endometrial Hyperplasia; Endometrium; Female; Geriatrics; Humans; Hydroxyprogesterones; Hyperplasia; Hysterectomy; Medroxyprogesterone; Menopause; Mestranol; Neoplasms; Norethindrone; Norethynodrel; Pathology; Progestins; Uterine Neoplasms | 1963 |
Hospitalizations among black women using contraceptives.
Topics: Adolescent; Adult; Age Factors; Black or African American; Breast Neoplasms; Carcinoma in Situ; Cardiovascular Diseases; Child; Contraceptives, Oral; Female; Georgia; Hospitalization; Humans; Intrauterine Devices; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Pelvic Inflammatory Disease; Pregnancy; Pregnancy, Ectopic; Risk; Time Factors; Uterine Cervical Neoplasms | 1985 |
Cervical cancer risk and use of depot-medroxyprogesterone acetate in Costa Rica.
Topics: Adult; Carcinoma in Situ; Carcinoma, Squamous Cell; Contraceptive Agents, Female; Costa Rica; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Regression Analysis; Risk Factors; Uterine Cervical Neoplasms | 1988 |
New Zealand contraception and health study: design and preliminary report. New Zealand Contraception and Health Study Group.
Topics: Adult; Carcinoma in Situ; Contraception; Contraceptives, Oral; Europe; Female; Follow-Up Studies; Humans; Intrauterine Devices; Medroxyprogesterone; New Zealand; Polynesia; Prospective Studies; Risk; Sampling Studies; Surveys and Questionnaires; Time Factors; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms | 1986 |
Intraepithelial cervical neoplasia in women using intrauterine devices and long-acting injectable progestogens as contraceptives.
Topics: Adolescent; Adult; Carcinoma in Situ; Cervix Uteri; Chile; Chlormadinone Acetate; Colposcopy; Contraceptive Agents; Delayed-Action Preparations; Female; Humans; Injections; Intrauterine Devices; Medroxyprogesterone; Middle Aged; Pregnancy; Uterine Cervical Neoplasms; Vaginal Smears | 1974 |
[Anticonception with the progestational hormone Depo-Provera].
Topics: Carcinoma in Situ; Contraceptive Agents; Delayed-Action Preparations; Female; Humans; Medroxyprogesterone; Uterine Cervical Neoplasms | 1973 |